Stephen Liu: Dr. Yi-Long Wu discusses adjuvant EGFR targeted therapy at RomeLung24

Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter:

“Dr. Yi-Long Wu discusses adjuvant EGFR targeted therapy at RomeLung24. Adjuvant osimertinib is our standard of care. Is the chemotherapy necessary? What is the optimal duration? When will we be able to use an MRD assay to guide therapy? Great talk by Thomas Wu.”

Source: Stephen Liu/X